Literature DB >> 627621

Dysfibrinogenaemia and liver cell growth.

R D Barr, M Allardyce, P W Brunt, J L McPhie.   

Abstract

From the evidence presented, it is proposed that 'dysfibrinogenaemia' represents the production of normal fetal fibrinogen by rapidly proliferating liver cells in both regenerating and neoplastic tissue. Prolongation of the reptilase clotting time, which was formerly believed to reflect dysfibrinogenaemia, may be rather the result of hepatocytic death.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627621      PMCID: PMC476725          DOI: 10.1136/jcp.31.1.89

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  A study of fibrinogen production by human liver slices in vitro by an immunoprecipitin method.

Authors:  P W STRAUB
Journal:  J Clin Invest       Date:  1963-01       Impact factor: 14.808

3.  Liver disease-morphologic considerations.

Authors:  H POPPER
Journal:  Am J Med       Date:  1954-01       Impact factor: 4.965

4.  Dysfibrinogenaemia and primary hepato-cellular carcinoma.

Authors:  R D Barr; N Ouna; J G Simpson; A F Bagshawe
Journal:  Q J Med       Date:  1976-10

5.  Activation of developmental genes in neoplastic transformation.

Authors:  W H Fishman
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

6.  Differentiation between neonatal hepatitis and biliary atresia by measuring serum-alpha-fetoprotein.

Authors:  P M Zeltzer; R C Neerhout; E W Fonkalsrud; E R Stiehm
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

7.  Fetal antigens in nonneoplastic conditions.

Authors:  L M Jerry; M G Lewis; G Rowden; A K Sullivan; R Pitzele; T Law
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

8.  Acquired dysfibrinogenaemia in acute and chronic liver disease.

Authors:  D A Lane; M F Scully; D P Thomas; V V Kakkar; I L Woolf; R Williams
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

9.  Fetal erythropoiesis following bone marrow transplantation.

Authors:  B P Alter; J M Rappeport; T H Huisman; W A Schroeder; D G Nathan
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

10.  Abnormal fibrin polymerization in liver disease.

Authors:  G Green; J M Thomson; I W Dymock; L Poller
Journal:  Br J Haematol       Date:  1976-11       Impact factor: 6.998

View more
  1 in total

1.  Acquired dysfibrinogenaemia in liver disease.

Authors:  J L Francis; D J Armstrong
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.